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ABSTRACT
A Study on the Applications and Toxicity Assessments of Carbon Nanotubes
in Tissue Engineering
by

Rena Baktur, Master of Science
Utah State University, 2011
Major Professor: Dr. Soonjo Kwon
Department: Biological Engineering
Carbon nanotubes (CNTs) are one of the most popular nanomaterials. There has
been increasing interest in the development and applications of carbon nanotubes due to
their huge potential in industrial and medical applications. Recent applications of carbon
nanotubes include development of scaffolds and drug delivery systems. Despite rapidly
emerging applications of CNTs, little is known about the impact of CNTs on cellular
processes, especially mesenchymal stem cell (MSC)’s differentiation. Also, the effects of
nanoparticle exposure under different conditions on cellular responses have not been well
characterized yet.
To characterize the effects of CNTs on creating nanoscale scaffolds for tissue
engineering, we incorporated multi-walled CNTs (MWCNTs) into reconstituted type I
collagen, and evaluated proliferation, differentiation, mineralization and inflammatory
response of MSC on those scaffolds. MWCNTs were homogeneously distributed in
collagen matrix, and strongly entrapped in collagen at the concentrations below 100 ppm.
Alkaline phosphatase (AP) activity and mineralized nodules of extracellular matrix (ECM)
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were monitored as osteogenic differentiation markers. AP activity was significantly
increased in 12 days after being replaced by differentiating media. Collagen enhanced
AP activity, and MWCNT-collagen scaffolds induced additional increase in AP activity.
The MSC released a significantly higher level of AP on MWCNT-collagen scaffolds than
the plastic surface did at day 16. An increasing percentage of ECM mineralization was
seen at day 16 after being replaced by differentiating media in the presence of MWCNTcollagen scaffolds. This study indicated the possibility of enhancement in MSC
differentiation in the MWCNT-collagen scaffolds. The increased level of differentiation
markers was due to the increased stiffness of the scaffolds for MSC. Our data indicated
that the collagen-MWCNT scaffolds might have the potential application to create
nanoscale scaffold materials for tissue engineering.
To illustrate the effects of interleukin-8 (IL-8) expression in human alveolar
epithelial cells (A549) under various exposure conditions of CNT, we measured the level
of IL-8 expression in the presence and absence of serum following exposure of SWCNTs.
The results demonstrated that the IL-8 expression was enhanced in the presence of serum.
The IL-8 expression kept increasing at low concentration even after removing SWCNTs
from the media. Further studies are required to characterize biological functions and
toxicological potentials of nanomaterials.

(99 pages)
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CHAPTER 1
INTRODUCTION
1.1 Background
Over the past decade, rapid development in nanoscience and nanotechnology has
resulted in the successful synthesis and characterization of various inorganic
nanomaterials.1-3

The unique physical properties of the nanopaticles, such as their

extremely small size, make them highly suitable for a wide range of biological and
medical applications. In all those nanoparticles, carbon nanotubes (CNTs) have been the
focus of intense research that was motivated by their unique physical, chemical and
mechanical properties, since they were discovered by Iijima in 1991.4
Carbon nanotubes (CNTs) are a new generation of materials possessing superior
mechanical, thermal, and electrical properties.5,6 They are mosaics of carbon atoms that
form graphene sheets and curl into seamless tubules. CNTs are classified as single-walled
CNTs (SWCNTs) and multi-walled CNTs (MWCNTs) based on the number of graphene
layers. CNTs exhibit unique properties that have made them an attractive material for the
application in molecular electronics,7 medical diagnostics, biosensors,8 and drug delivery
carriers.9
The CNTs have been proposed for biomedical applications, such as cell tracking
and labeling, nano-sensors, and vehicling for controlled release of drugs, and vehicling
for delivery of bioactive agents. Synthetic polymers and CNTs have demonstrated
promise for these materials in neural and orthopedic tissue engineering applications.
When CNTs are used as scaffold materials in regenerative medicine, especially in bone
tissue engineering, they are in direct contact with the bone. These included implants for
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arthroplasty, bone fracture, dental treatment and scaffolds for bone tissue regeneration.
The reaction of the bone cells to CNTs is critical for functional maintenance of the
biomaterials for a long time in the tissues. Recently, there have been several reports on
the application of CNTs for scaffolds. For example, CNTs coated with bioactive
molecules were used as substrates for nerve cell growth.10 Also in Webster’s study they
reported that carbon nanofibers increased osteoblast functions. MacDonald reported a
collagen-SWCNT composite for cell culture substrate.11 However, there is a limit amount
of information about the CNT and collagen mixture scaffold for stem cell growth. This
give researchers a new idea to use collagen-CNT composite to check stem cell
biocompatibility.
On the other hand, enthusiasm for CNTs use has been tempered by relevant
concerns regarding their toxicity. The high aspect ratio of CNTs made them easily
become airborne and inhaled. The evaluation of their pulmonary effects has received a
considerable amount of interest and emerge studies investigate the toxicity of CNTs in
vivo and in vitro. Most of the emerging literatures on the toxicity of CNTs on the lung
tissue of various animal models have been reported and appared to be inconsistent amony
the research findings. Some of the researches confirmed that CNTs can have toxic effects,
and some of the toxic effects in mammals have been attributed to high concentration of
CNTs. There also have been a range of in vitro studies using human or mammalian cell
lines to investigate the toxicity mechanisms, which suggest that oxidative stress,
inflammation reactions, and immune toxicity may be key features of CNT toxicity. Most
of the studies that suggest CNT toxicity used a high concentration of CNT to expose the
cell line or to inject the animal. However, there was no specific number about how much
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CNT will get inhaled in to human body and in the environment. Small amount of CNTs
inhaled effect is still unknown and the machines of CNTs to airway inflammation
reactions need to be indicated.
1.2 Motivation and Objectives of Research
Carbon nanotubes (CNTs) and other carbon nanomaterials are of interest for
biological and medical applications because of their high chemical durability, mechanical
strength and electrical properties. Studies on the applications of carbon nanomaterials
have been carried for the substrate of cell culture,12-14 drug delivery systems15,16 and
medical implant materials.17 Several studies have shown that cells have high affinity to
CNTs.18-20 Other studies that showed the bone cell affinity to CNTs and bone formations
on sintered MWCNTs21. During those studies, MacDonalds provided a good idea for
using collagen and CNTs to make a good composite material, which show high
mechanical strength and good cell viability. However, until now there are no studies that
use collagens - CNTs composite materials to make a scaffold to culture mesenchymal
stem cells (MSC), especially a good composite material with good optically transparent.
Thus, in our study, we
a) Designed CNTs-collagen composite scaffolds using different types of MWCNTs
(functionalized and non-functionalized) with good optically transparent.
b) Estimated mesenchymal stem cell’s viability, differentiation, mineralization and
inflammatory response on those types of CNTs-collagen scaffolds.
c) Measured the mechanical properties of those CNTs-collagen scaffolds.
Carbon nanotubes have gained enormous popularity due to a variety of potential
applications which will ultimately lead to increased human and environmental exposure
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to these nanoparticles. The lung is regarded as one of the main portals of entry for
nanoparticles, which emphasizes the importance of pulmonary toxicity evaluation. The
lung epithelium plays an important role in the modulation of inflammatory processes by
releasing inflammatory cytokines such as IL-8 and nitric oxide 22-24. However, the effects
of concentration, exposure time, media component and aggregation of CNTs on cellular
toxicity and their mechanisms have not been well defined. In the second study, we
estimated effect of exposure conditions on SWCNT-induced inflammatory response in
human alveolar epithelial cells. This study was spurred by the following fundamental
questions:
a) What other environmental factors (e.g. exposure time, media components) may affect
the SWCNTs related inflammatory responses or cellular toxicity?
b) Is SWCNTS induced inflammatory response alleviated by removing SWCNTS
following exposure?
Chapter 1 describes general introduction and motivations of studies on the
applications and toxicity assessments of carbon nanotubes in tissue engineering. In
chapter 2, Literature Review introduced researches about the CNTs biomedical
applications, especially in bone tissue engineering applications. It also looked at the
toxicity study of CNTs, both in vivo and in vitro, especially on human alveolar epithelial
cells. Chapter 3 exhibited the research related to effect of Carbon nanotubes –collagen
composite

scaffold

on

mesenchymal

stem

cell

proliferation,

differentiation,

mineralization and inflammatory response. Chapter 4 contained the study about the effect
of exposure conditions on SWCNT-induced inflammatory response in human alveolar
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epithelial cells. Based on the experimental data in chapter 3 and chapter 4, conclusions
and recommendations were given in chapter 5.
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CHAPTER 2
LITERATURE REVIEW
2.1 Carbon nanotubes
Carbon nanotubes (CNTs) are one of the new class materials for industrial and
biomedical applications. Sumio Iijima discovered multiwall CNT (MWCNTs) in 1991 by
an arc-discharge method.1,2 After two years, he made the observation of single-walled
nanotubes (SWCNTs).3 Since then, CNTs have captured the attention of researchers
worldwide.
CNTs are allotropes of carbon with a cylindrical nanostructure. They are a
seamless cylindrical sheet of graphite whose diameter is nano scale and its aspect ratio
(diameter verses length ration up to 132000000:1) is significantly larger than any other
materials.4 CNTs not only exhibit extraordinary strength but also are the stiffest materials
have been found on the earth yet.
CNTs are categorized as SWCNTs and multi-walled nanotubes (MWCNTs). A
SWCNT is a nano size tube formed by bonded carbon atoms arranged in a hexagonal
pattern. An individual SWCNT is a very thin tube at least several micrometers long, the
diameter of the SWCNTs are vary between about 0.7 and 3 nm,5 with an aspect ratio
greater than 1000.6 Structurally, it resembles a rolled up single layer of graphite sheet.
MWCNTs have two or more concentric layers with various diameters (generally range
from 10 to 200 nm)7 and lengths. MWCNTs generally exist in single tubes and form very
few bundles. Both of SWCNTs and MWCNTs have van der Waals forces between the
molecules, this causes them to aggregate into microscopic bundles or topes. However, the
MWCNTs are less effective than the SWCNTs.8
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On the other hand, the lack of solubility and the difficult manipulation in any
solvents have imposed great limitations to the use of CNT. They can be dispersed in
some solvents by sonication, but precipitation immediately occurs when this process is
interrupted. It has been demonstrated that CNT can interact with different classes of
compounds9-11. Extensive research on CNTs focuses on modifying CNTs by adding
specific chemical groups, leading to a significant change in their properties (Like –OH, COOH, -NH2).
Commercially, CNTs are produced from carbon atoms found in graphite by arc
discharge , by pulsed laser vaporization12, and by a chemical-vapor deposition (CVD)
process13. Nowadays, the most common synthesis method is the HiPco process which
was developed in the Smalley’s laboratory14. CNTs samples invariably contain some
residual impurities. Usually they are metals, organics, and support materials. The most
commonly used metals in CNT synthesis are Co, Fe, Ni and Mo. Post production
processing removes the majority of metal catalyst. However, CNTs may still contain
some residual metal by mass. In our research, we used many different types and different
sizes of CNTs. All CNTs we bought are made by HiPco method. The Table 2.1 showed
the detail information about the MWCNTs we used in our research.
2.2 Carbon Nanotubes Applications
The nano scale of nature has logically given rise to the interest in using
nanomaterials for tissue engineering and biomedical field. In the medical field,
biomaterials are expected to be developed using CNTs for clinical use. Since 2000, with
CNT high aspect ratio, electrical and physical properties, there has been an approximate
doubling each year of articles related to CNT for use in biomedical application. Also the
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research have increased rapidly from 2005 and continue to increase (Figure 2.1).15
However, there have been only a few cases of a truly clinical application to date, and
therefore the use of CNTs in biomaterials must be considered to be at an early
experimental stage.
2.2.1 Application in biomedical: cancer, drug, and matrix
Applications of CNTs in the field of biotechnology have recently started to
emerge, raising great hopes. CNTs have been proposed as a component for DNA and
protein biosensors

16,17

, ion channel blockers

18

and bioseparators and biocatalysts

19

.

Concerning the biomedical applications of CNTs, their use is becoming relevant in
neuroscience research and tissue engineering. Cell tracking and labeling, sensing cellular
behavior, augmenting cellular behavior and enhancing tissue matrices are the four areas
that CNT can be used in tissue engineering

20

. CNTs have also been used as a new

platform to detect antibodies associated with human autoimmune diseases with high
specificity 21. In a similar context, CNT covalently have been modified at their open ends
with DNA and RNA, and have led to innovative systems for hybridization of
complementary DNA strands allowing for ultrasensitive DNA detection 22.
Carbon nanotubes have potential novel application in nanomedicine as
biocompatible and supportive substrates, and as pharmaceutical excipients for creating
versatile drug delivery systems. The applications of CNTs as drug excipients are of
interest, given their capacity to interact with macromolecules such as proteins and DNA
23

. There are some research showed that functionalized carbon nanotubes used as vectors

for in vitro delivery of small molecules

24

, a potential vector for transporting proteins,

10
peptides, and genes in to the nucleus

25-27

. Efforts are continuing to develop novel

systems for the delivery of protective antigens.
Table 2.1 Carbon Nanotubes (CNTs) detail information
Types

MWCNT
Short MWCNT
MWCNT-OH
Short MWCNT-OH
MWCNT-COOH
Short MWCNT-COOH

Outside
diameter

20-30nm
20-30nm
20-30nm
20-30nm
20-30nm
20-30nm

Inside
diameter

5-10nm
5-10nm
5-10nm
5-10nm
5-10nm
5-10nm

Length

10-30µm
0.5-2.0µm
10-30µm
0.5-2.0µm
10-30µm
0.5-2.0µm

Components Contents (%)
C

Cl

Fe

Ni

98.35
98.34
98.37
98.32
98.39
98.34

0.45
0.47
0.47
0.48
0.45
0.46

0.26
0.24
0.23
0.25
0.23
0.25

0.94
0.94
0.93
0.94
0.93
0.94

35
review

Number of Articles

30

research

25
20
15
10
5
0
2000 2001 2002 2003 2004 2005 2006 2007 total
Years

Figure 2.1 Number of publications on CNTs applications in biomaterials by year
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CNTs are also potential biocompatible materials that can serve as a supportive
matrix. The matrix plays a critical role in tissue engineering. It is responsible for defining
the space the engineered tissue occupies and aiding the process of tissue development.
Compared to the polymers, CNTs can easily functionalized and have good mechanical
strength. CNTs have the potential for providing the need structural reinforcement for
tissue scaffolds. Adding CNTs in to polymer can significantly improve the mechanical
strength of the materials. In Wang et.al research they found MWCNT blended with
chitosan showed significant improvement in mechanical properties compared with those
without chitosan 28.
In vitro studies have shown that CNT as a scaffold has successfully grown several
different types of cells. For instance, smooth muscle cell have been successfully grown
on the SWCNT with collagen scaffold

29

. CNT scaffold support L929 mouse fibroblasts

growth 30. CNT are widely used as a mimic neural fibers scaffold to guide neurite growth
30-34

. Nowadays, researchers try to use CNT as a scaffold for bone cell growth.

2.2.2 CNTs applications in bone tissue engineering
A major goal in bone bioengineering is to create artificial scaffold materials that
have the capacity to sustain bone cell growth, proliferation and increment or replace bone
tissue. When CNTs are used in biomaterials to contact with bone, the reactions of cells
including bone tissues to CNTs are critical. These reactions are especially important
when CNTs are used for bone tissue engineering. These cells are mainly osteoblasts,
osteocytes, osteoclasts, and chondrocytes. Osteoblasts, the bone forming cells, proliferate
on the bone surface, produce and secrete bone matrix proteins. As they progress through
stages of cell differentiation under hormonal control, they mineralize the matrix by means
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of production of hydroxyapatite crystals. There have been several studies on the influence
of CNTs on osteoblastic cells which are representative of these cells.
There are some published studies on the application of CNTs to biomaterials
associated with bone. What they did basically was expose bone cell to different types of
the CNTs, then checked cell proliferation and differentiation. For examples, in Zhang et
al investigated effect of SWCNT, double walled carbon nanotubes (DWNTs) and
MWCNT on the proliferation, differentiation, adipocytic transdifferentiation and
mineralization of primary osteoblasts. They found the treatment of CNTs could reduce
the viability of primary osteoblasts and inhibit the mineralization of osteoblasts in a dosedependent manner. Also CNT reduced the adipocytic transdifferentiations. However, the
inhibition was not strong enough to reverse the cytotoxicity and suppression on viability
and mineralization of primary osteoblasts 35. Similar results were found by Zanello group.
They concluded that CNTs sustain osteoblast growth and bone formation. CNTs showed
promising biocompatibility with osteoblast cells and appeared to modulate the cell
phenotype. Thus CNTs represent a potential technological advance in the field of bone
bioengineering36. In Narita et al’s study they showed that MWCNTs inhibit osteoclastic
bone resumption in vivo.MWCNTs inhibit osteoclastic differentiation and suppressed a
transcription factor essential for osteoclastogenesis in vitro 37. Recently, the main aim of
many studies is to examine the effects of CNTs on mesenchymal stem cell viability,
proliferation, and phenotype. Mooney et al’s study revealed that functionalized CNTs
were easier to disperse in human mesenchymal stem cell media. Study clarified the
COOH- functionalized SWCNT were least toxic to the cells, and the CNT had no adverse
effects on cell biocompatibility, proliferation, or differentiation 38.
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Since attention has been paid to the use of CNTs as biomaterials in contact with
bone, it is critical to understand the reaction of bone cell to CNTs. Some of the studies
used CNT films to test the effects of CNTs on bone cells. Kalbacova’s groupindicated
that differently prepared SWCNT films are not toxic for human osteoblasts and could be
used for biomedical applications

39

. In Aoki et al’s study they made CNT scaffold by

vacuum filtration. And cell proliferation and morphology were investigated using a
scanning electron microscopy. Osteoblast cells on CNTs showed excellent proliferation
with extension of cell morphology in all directions

40

. After two years, Aoki’s group

investigated the dependence of biocompatibility of carbon materials on crystal structure
with the aim of developing biomedical applications. They used SWCNT and MWCNT as
scaffolds for cell culture and compared with graphite (GP). They discovered the
osteoblast cell responses in terms of cell morphology, cell proliferation, and ALP
activities were quite different between those carbon atom materials. With CNTs scaffolds,
cell growth, proliferation, and functions were higher than GP. In particular, SWCNT cell
proliferation and ALP activity were higher than on MWCNT. They thought those results
could be due to the surface topology and chemical properties of the substrates 2. However,
the SWCNT films showed different results to MSC. SWCNT films and carbon fibers
reduced the metabolic activity of both investigated cell types in different ways, as the
reduction is more produced for carbon fibers. The high quality SWCNT films are
apparently not toxic for the MSC under the conditions used. The observed reductions of
metabolic activities can
materials

41

be occasioned by the surface morphology of the carbon

. Park’s results clearly showed that MSC exhibited preferential growth on

CNT patterns, and the cell culture results suggested that the CNT patterns didn’t have a
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harmful effect on the MSC. Those results investigated CNT patterns have enormous
potential as a new platform for basic research and applications using stem cells 42.
All those studies discussed above are using pure CNTs, however, reinforcement
of naturally derived polymers with carbon nanotubes is another promising area that is just
beginning to be explored. In 2006, Chlopek et al. fabricated MWCNT with polysulfone
PSU (which is currently used in medicine) and investigated their effect on osteoblast. The
cellular test performed in this study confirmed a good biocompatibility of nanotubes.
Like high level of viability of the examined cells in contact with the nanotubes, the
unchanged level of oteocalcin released from osteoblasts, the lack of proinflammatory IL6;these effects point out a good cellular biocompatibility 43. Type I collagen is one of the
most studied molecules in biology because of its very important physical and biochemical
functions in the extracellular matrix of many tissues, and has shown promise as a matrix
for regenerative medicine 44,45. MacDonald et al. reported a collagen-SWCNT composite
for the cell culture substrate. The SWCNTs were strongly entrapped by collagen and the
composite showed high mechanical strength. And the cell showed good cell viability.
The affinity between collagen and CNTs was expected

29

. Recently, Terada et

al .developed a transparent MWCNTs coating for cell culture dishes and estimated its
properties for cell culture. In this research, they found rat osteoblast-like cells cultured on
the MWCNT-coated dish which showed slightly lower viability and proliferation
compared to the collagen-coated dish. The cell adhesion on the MWCNT coated dish was
much higher than that on the collagen-coated dish. Therefore, CNT-coating for dishes
will be a useful new material for cell culture

46

. However, there is only limit research

about collagen-CNT composite materials, especially on stem cell research.
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2.3 Mesenchymal Stem Cells
It is commonly believed that stem cell is involved in continuous maintenance and
repair of most tissue types. Taken into consideration that stem cells are capable of self
renewal and they share the ability to differentiate in multiple lineages. This class of cells
is of paramount importance for an organism, not only during development, but also
during adulthood with respect to cellular homeostasis. Stem cells for non-hematopoietic
tissues, which can be derived from bone marrow are commonly termed mesenchymal
stem cell (MSC). MSCs are considered a readily accepted source of stem cells because
such cells have already demonstrated efficacy in multiple types of cellular therapeutic
strategies, especially in bone tissue regeneration strategies 47.
MSC differentiation, morphology, markers expression and inflammatory response
The multiline differentiation potential of MSC populations derived from a variety
of different species has been extensively studied in vitro since their first discovery in the
1960s

48

. MSC has the capacity to differentiate into all connective tissue cell types,

including bone, cartilage, tendon, muscle, marrow, fat and dermis. In vitro studies
showed successfully differentiation in a variety of cell lineages, including osteoblasts,
chondrocytes, adipocytees, fibroblasts, myoblasts and cardiomyocytes, hepatocytes,
tenocytes, cenocytes, and even neurons.49-52
The differentiation can be simulated in vitro by adding the proper differentiating
supplements to MSC, including dexamethasone (Dex), L-ascorbic acid (L-AA), and βglycerophosphate (β-GP), each of them play a unique role in the differentiation
process.53-56 For convenience, the differentiation process of the osteoblast committed
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MSC is divided into several stages, like osteoprogenitors, preosteoblasts, osteoblastes,
osteocytes, and bone lining cells (Figure 2.2).
Osteoprogenitor cells: it is a mainly functionalized cell type. Osteoprogenitors
are able to clonally generate cells of osteoblast lineage but lack self-renewal capacity 57.
The cell morphology is spindles shaped and reside in close proximity to the preosteoblast
layer with a distance from bone formation surface in the periosteal layer of bone 58.
Preosteoblasts: this type of cell is considered as a precursor of the oteoblasts and
indentified in part by their localization in the adjacent one or two cell layers’ distance
from the osteoblasts lining bone formation surfaces. Although preosteoblasts resemble
osteoblasts histologically and stain for ALP acitivity, they have not yet acquired many of
the other characteristics of fully mature cells, and unlike osteblasts, preosteoblasts are
thought to possess a limited proliferation potential.
Osteoblasts: it is a post proliferative, strongly alkaline phosphatase positive cell
lining bone matrix at sites of active matrix production. This type of cell has a large
nucleus, enlarged Golgi apparatus, and extensive endoplasmic reticulum, which are
typical features of cells highly active in protein production.59
Osteocytes: It is a non-proliferative, terminally differentiated cell of the
osteoblasts lineage. They are non-migratory cells, locked inside small lacunae in the
mineralized bone matrix or the newly formed osteoid. Compared with mature osteoblasts,
the osteocytes are smaller and have decreased ALP activity and cytoplasmic organelles.
However, there is an emerging consensus that osteocytes play an important role in the
maintenance of bone structure.60-62
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Bone lining cells: These types of cells are flat, thin and elongated, covering most
if not all the non-remodeling bone surfaces. Bone lining cells are considered
postproliferative, inactive in matrix production and may take part in mechanotransduction
and protection of the bone matrix from osteoclastic resorption.63 Another feature of the
bone lining cells is their potential to be reactivated to cuboidal, which can active
osteoblasts in response to particular stimuli.64
The cells change dramatically in morphology from their in vivo state. However,
this compartmentalization is problematic for in vitro studies. Therefore, using molecular
markers to evaluate the differentiation of MSC is most practical. The MSC differentiation
is associated with temporal modification in the expression of a set of macromolecules.
These molecules include membrane-associated enzymes (such as Alkaline phosphatase),
bone matrix protein (such as type I collagen), and different cytokine receptors. Those
macromolecules not only play important roles in regulating cell proliferation and function
but also provide a panel of markers that reflect the transitional stages in osteoblast
development (Figure 2.3).
Type I collagen: It is a primary product of osteoblasts during bone matrix
formation, constituting approximately 90% of the total organic matrix in mature bone 65.
In osteoblast lineage cells, type I collagen is clearly expressed before the preosteoblast
stage, and it has been documented that up-regulation of type I collagen occurs prior to upregulation of any other matrix molecules and prior to ALP.66
Alkaline phosphatase (ALP): Alkaline phosphatase is a hydrolase enzyme
responsible for removing phosphate groups from many types of molecules, including
nucleotides, proteins, and alkaloids. It is the most frequently used phenotypic marker to
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evaluate bone activities 67. The major role of ALP in bone is to facilitate mineralization.
It is abundantly presents in membranes of osteoblasts and matrix vesicles when it
covalent bounds to glycosylphosphatidylinositol (GPI).68 In addition, ALP can also be
detected in subpopulations of osteoprogenitors and preosteoblasts, well before
mineralization and prior to the expression of the noncollagenous matrix molecules.69 That
is why ALP plays as a membrane-bound receptor involved in osteoprogenitor osteoblast
adhesion, migration, and differentiation.70
Osteocalcin: Osteocalcin is a carboxylated bone protein also known as bone Gla
protein. It is the most abundant non-collagenous protein of bone and has a very narrow
expression pattern. Osteocalcin is undetectable in preosteoblasts and expressed only by
the mature osteoblasts and osteocytes. Therefore, the latest expressed osteoblast makers
is osteocaclin.71,72
Interleukin-6 (IL-6): A variety of publications suggest that treating inflamed
cells with nano-particles decreases the cells’ inflammatory responses.73,74 Cytokine
expression has been measured for MSC isolated from rat bone; results indicated that MIF,
IL-8, Serpin E1, GROα, IL-6, MCP-1, and SDF-1 were the most highly expressed 4. IL-6
is a multifunctional cytokine that can activate target genes involved in proliferation,
differentiation, survival and apoptosis in a variety of cells.72,75 Indeed, researchers have
shown that the production of interleukin-6 by bone marrow cells is regulated by sex
steroids.76-78 Upon loss of gonadal function, osteoclast and osteoblast formation in the
marrow increase. Both changes are apparently mediated by increase in the production of
IL-6.79 A pathogenic role for IL-6 and its receptor has been also demonstrated in other
systemic diseases with increased bone remodeling, such as hyperparathyroidism and
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hyperthyroidism.80 IL-6 activates nuclear factor κB (NF-κB) through the mitogenactivated protein kinase (MAPK) signal transduction pathway, which regulates
expression of the receptor activator of NF-κB ligand (RANKL).81 through the IL-6gp130-STAT3 signaling pathway.82 RANKL then binds to receptor activator NF-κB
(RANK) on the surface of osteoclast progenitor cells, inducing the formation of a mature
osteoclast.83 Therefore, IL-6 cytokines stimulate osteoblast differentiation and bone
formation.

Figure 2.2 1. preosteoblast, 2. preosteoblastic osteoblast, 3. osteoblast, 4. osteoblastic
osteocyte (Type I preosteocyte), 5. osteoid-osteocyte (Type II preosteocyte),
6. Type III preosteocyte, 7. young osteocyte, 8. old osteocyte. Diagram
drawn by Tim Fedak (www.figs.ca).61
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Figure 2.3 Biomarker produced during different stages of MSC differentiations.
2.4 Toxicity Assessment of Carbon Nanotubes
CNTs are useful materials with numerous technological potentials. When CNT
synthesis moved from laboratories to factories and the products became commercial
commodities, CNTs began to come under toxicological scrutiny.
2.4.1 In vivo toxicology studies: rat, pig, fish
Most of the emerging literatures on the toxicity of CNTs have shown the model of
respiratory exposure with consequent concerns about lung injury, inflammation and
possible early signs of tumor formation in the lung (Table 2.2).84
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Table 2.2 Pulmonary toxicity studies of CNTs in animals 84
Test materials

Metal content

Animal species

References

Soot containing
CNTs

Co/Ni
No info on %

Guinea pig

Huczko et al.,2001

SWCNTs

Ni:10%

Mouse

SWCNTs

Fe:26.9%
Mo:0.95%
Ni:0.8%
Fe:2.1%

Mouse

Lam and
McCluskey, 2000
(unpublished report)
Lam et al., 2004

Mouse

Lam et al., 2004

Ni:26%
Y:5.0%
Fe:0.5%
Ni:5%
Co:5%

Mouse

Lam et al., 2004

Rat

Warheit et al., 2004

SWCNTs, purified

Fe:0.23%

Mouse

Shvedova et al.,
2005

MWCNT

Co:0.95%
Fe:~1%

Rat

Muller et al., 2005

SWCNTs, purified

SWCNTs

SWCNTs

The first study of a carbon nanotube product in Chunea pigs conducted by
Huczko’ et al of Warsaw University was published in 2001.85 The results of this
exploratory study showed that the intratracheal instillation of fibrous carbon
nanostructures does not change pulmonary function and does not induce any measurable
inflammation in bronchoalveolar space in CNTs-exposed guinea pigs. Thus, based on this
research, they thought working with soot containing carbon nanotubes is unlikely to be
associated with any health risk.
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However, after three years, the first study of SWCNT toxicity , in which lung
histopathology in exposed mice was examined,86 was conducted to address NASA’s
concern that workers in occupational settings could be exposed to the airborne dust of
this novel materials of unknown toxicity. In Lam, C. W’s study they used three products
which were made by different methods and contained different types and amounts of
residual catalytic metals. Mice were intratracheally instilled with 0, 0.1, or 0.5 mg of
carbon nanotubes, a carbon black negative control, or a quartz positive control, and then
they were euthanized 7 days or 90 days after the single treatment for a histopathological
study of the lungs. All nanotube products induced dose-dependent epithelioid granulomas
and, in some cases, interstitial inflammation in the animals of the 7 days groups. These
lesions persisted and were more pronounced in the 90 days groups; the lungs of some
animals also revealed peribronchial inflammation and necrosis that had extended into the
alveolar septa. The lungs of mice treated with carbon black were normal, whereas those
treated with high-dose quartz revealed mild to moderate inflammation. These results
show that, for the test conditions described here and on an equal-weight basis, if carbon
nanotubes reach the lungs, they were much more toxic than carbon black and can be more
toxic than quartz, which is considered a serious occupational health hazard in chronic
inhalation exposures.
Not only in the mouse, Warheit and his research group of Du Pont Company also
conducted toxicity study in rats of a SWCNTs product made by their company.87 In this
study the lungs of rats were instilled either with 1 or 5 mg/kg of the SWCNT, quartz
particles (positive control), carbonyl iron particles (negative control), phosphate-buffered
saline (PBS) + 1% Tween 80, and graphite particles (lung tissue studies only). Following
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exposures, results from the lung histopathology component of the study indicated that
pulmonary

exposures

to

quartz

particles

(5mg/kg)

produced

dose-dependent

inflammatory responses, concomitant with foamy alveolar macrophage accumulation and
lung tissue thickening at the sites of normal particle deposition. Pulmonary exposures to
carbonyl iron or graphite particles produced no significant adverse effects. Pulmonary
exposures to SWCNTs in rats produced a non-dose-dependent series of multifocal
granulomas, which were evidence of a foreign tissue body reaction and were nonuniform
in distribution and not progressive beyond 1 month post exposure. The physiological
relevance of SWCNT-induced multifocal granulomas findings should ultimately be
determined by conducting an inhalation toxicity study. MWCNTs have been shown to
produce lung lesions similar to those observed in studies with SWCNTs. The Muller’s
research group tested two forms of MWCNTs, and they found that 60 days after rats were
each given a single ITI does of 0.5, 2, or 5mg MWCNT, their lungs showed inflammation,
granulomas, and fibrosis.88
The concerns about the toxicity of carbon nanotubes on mammalian studies have
increased, and there is even one article showing the toxicity of SWCNT on aquatic life
using rainbow trout.89 They used a semi-static test system to expose rainbow trout to a
freshwater control, solvent control, 0.1, 0.25 or 0.5 mg/L SWCNT for up to 10 days.
From this study they found that SWCNTs are respiratory toxicant in trout.the fish were
able to manage oxidative stress and osmoregulatory disturbances, but other cellular
pathologies raised concerns about cell cycle defects, neurotoxicity, and some unidentified
blood borne factors that possibly mediate systemic psthologies.
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2.3.2 In vitro toxicology studies
Human exposure to nanoparticles in the air is a complex process. Particle sizes
can range from individual particles of around 50 nm or much less in vehicle exhausts.90
The growth of larger aggregates of particles is associated with coagulation or
condensation processes in the urban air

91

. Another approach used in toxicological

investigations is to study the responses of individual cell types with a view of obtaining
evidence on the mechanisms of toxicity. Toxicological studies are assessing respiratory
exposure of nanoparticles in vitro. These raise some concerns for health effects, but
without measurements of manufactured nanoparticles in the atmosphere, it is difficult to
precisely quantify the current risk to the general public. That is why many researchers
tried the different dose and exposure time of CNT on different cells. Several in vitro
assessments of the toxicity effects of manufactured nanomaterials have been carried out
(Table 2.3).
Overall, these studies suggest that oxidative stress is one possible mechanism of
toxicity. This may be also linked to inflammation responses. Shvedova et al.94 showed
that SWCNT cause oxidative stress and cellular toxicity to HEK. There are also results
that come from skin cell culture,94 like Monteiro-Riviere et al. found that MWCNT
caused a time dependent release of the pro-inflammatory cytokine, Interleukin 8 (IL-8),93
from human epidermal keratinocytes. Other toxicity effects at the cellular level include
changes in cell growth and turnover. In Cui et al.92 study they found the inhibition of
HEK 293 cell proliferation, induced cell apoptosis, and decreased cellular adhesive
ability.
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Table 2.3 Examples of the toxic effects of CNTs from in vitro studies

Nanomaterial

Dose/Exposure time

Cells

Study

SWCNT

Serial dilutions from
0.78 to 200ug/ml

Human HEK 293
(human embryo
kidney) cells

Cui et al. 2005 92

MWCNT

Serial dilutions of
0.2-0.1 mg/ml for 1,
2, 4, 8, 12, 24 and 48
hour

Human epidermal
keratinocytes (HEK)

Monteiro-Riviere et
al. 2005 93

SWCNT

0.06-0.24mg/ml for
up to 18 hour

HEK cells in culture

Shvedova et al. 2003

SWCNT

0, 400,800 μg/ml
For 24 hour

A549 cell

Davoren et al. 2007 95

SWCNT

30 and 60 μg/ml for
1, 24 and 48 hour

Human macrophage
cells

Fiorito et al. 2006 96

SWCNT

1mg/ml for 4 days

Human epithelial-like
Hela cells

Yehia et al. 2007 97

94

The lungs as a whole have been subjected to testing for the potential hazards of
inhalation exposure to carbon nanotubes. The cytotoxicity effect of CNTs has been
evaluated in vitro on culturing lung cells. Kisin et al. 98 have reported loss of viability in
lung fibroblast cell line in a concentration and time dependent manner after the exposure
of cells to SWCNT. The serum supplementation to the cell culture medium probably
made the CNT non toxic, as demonstrated by Yehia et al.97 Human epithelial-like lung
cell line (A549) has been widely used in the in vitro cytotoxicity assessment of SWCNT.
Maria Davoren’s95 study revealed that the SWCNT have low acute toxicity after exposure
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of A549 cells to a wide dose range of SWCNT (1.56-800 ug/ml) for 24 hours. And in this
study, they found greater SWCNT toxicity was observed in absence of serum. Casey et
al.99 demonstrated that the cause of cytotoxicity to the A549 cells to be due to media
constituent depletion and referred to it as a case of false positive result. On the other hand,
some studies showed the effect of the CNTs to A549 cells. For example , the research
group in Korea found little cytotoxic effects on the proliferation and viability of A549
and other three cell lines expose to the SWCNT concentrations (<250-500ug/ml) within
48 hours. However, exposing A549 cells to high SWCNT concentrations (250-500ug/ml)
for 72 hours resulted in an inflammatory response with oxidative stress and membrane
damage 100. Herzog et al. showed that exposing A549 cells to SWCNT samples can lead
to the suppression of a variety of inflammatory mediators including IL-8, IL-6 and MCP1 in vitro

101

. At the same time, researchers demonstrated that MWCNTs are able to

induce inflammatory responses in vitro. Oxidative stress and NF-κB activation seem to
play an important role in MWCNTs-induced cytokine production, which suggests that
MWCNTs exert proinflammatory effects by a mechanism that is mediated by ROS and
NF-κB 102.
Despite these details on effects in cell culturesand respiratory effects in vitro, our
knowledge on CNTs toxicity is incomplete. Some results indicated CNTs to be highly
toxic

77,103-105

, and others showed low toxicity or no signs of toxicity at all

106-108

. In

addition, many of these experiments used a “proof of principle” approach using relatively
high doses to ensure a clear demonstration of toxicity effect. However, these types of
experiments do not generally give data on “no effect” levels that are of interest in risk
assessment. More detailed studies are needed.
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CHAPTER 3
CARBON NANOTUBE-COLLAGEN SCAFFOLDS FOR MESENCHYMAL
STEM CELLS’ DIFFERENTIATION: CHANGES IN ALKALINE
PHOSPHATASE EXPRESSION AND MINERALIZATION
3.1 Abstract
Studies of the application of carbon nanotubes (CNTs) have been carried out for
the substrates of cell culture, drug delivery systems, and medical implant materials.
However, little is known about the impact of CNTs on cellular processes such as
adhesion, proliferation, and differentiation. We hypothesized that augmenting the
properties of naturally derived polymers (collagen, in this study) through the
incorporation of CNTs might enhance osteogenic differentiation of MSCs in vitro. In this
study, we incorporated different concentrations and types of multi-walled CNTs
(MWCNTs) into reconstituted type I collagen, and evaluated proliferation, differentiation,
mineralization, and inflammatory response of mesenchymal stem cells (MSCs) on these
MWCNT-collagen scaffolds. MWCNTs were distributed in collagen matrix, and strongly
entrapped in collagen at the concentrations below 100 ppm. Alkaline phosphatase (AP)
activity and mineralized nodules of extracellular matrix (ECM) were monitored as
osteogenic differentiation markers. Collagen itself enhanced MSCs differentiation and
mineralization due to its nanoscale feature. MWCNTs added to collagen scaffolds
induced an additional increase in MSCs differentiation and mineralization. MWCNTcollagen scaffolds induced significantly higher level of AP activity than plastic surface
and increased ECM mineralization 12 days after replacement with differentiating media.
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Additional increase in MSC differentiation and mineralization may be due to the
increased stiffness and tensile strength of MWCNT-collagen scaffolds.
3.2 Introduction
There have been significant advances in cell-based therapy and tissue engineering
for the repair and replacement of damaged tissues and organs. Nanotechnology has
emerged showing great potential for the creation of the next generation of materials.
Recent researches have more focused on the role of nano-structure and nano-scale
materials for tissue engineering applications.1 Carbon nanotubes (CNTs) were first
introduced by Oberlin et al. in 19762 and their development and applications have been
dramatically increasing in biosensors, tissue engineering, and biomedical devices,
because of their unique electronic, chemical and mechanical properties3-6. Studies of the
application of carbon nanomaterials have been carried for the substrate of cell culture7-9,
drug delivery systems,10,11 and medical implant materials. The applications of CNTs have
tremendous potentials for them as substrates of cell cultures, drug delivery systems, and
medical implantable materials.10-13 Nanomaterial-based scaffolds can provide many
critical features of the microenvironments for cell adhesion, proliferation, and
differentiation. However, little is known about the impact of CNTs on cellular processes
such as adhesion, proliferation, and differentiation. Nanomaterial-based scaffolds can
provide many critical features of the microenvironments for cell adhesion, proliferation,
and differentiation.
A variety of new approaches and new materials have been developed for creating
improved scaffolds with engineered tissues.14,15 The advent of the field of
nanotechnology has stimulated an interest in creating nanocomposite materials for a
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variety of purposes, including biomedical applications. Initial studies using composites of
synthetic polymers and CNTs have demonstrated promise for these materials in neural
and orthopedic tissue engineering applications. The reinforcement of naturally derived
polymers (e.g. ECM) with carbon nanotubes has been attempted to compensate for ECM
scaffold limitations such as weak mechanical properties, lack of electrical conductivity,
the absence of adhesive and microenvironment-defining moieties.16 CNTs have diameters
ranging from 0.7 to 2.0 nm (typically around 1.0 nm), with the lengths that are often
hundreds or thousands of times greater than their diameter.17 This high aspect ratio of
CNTs plays an important role as in fiber-reinforced composite materials additives.18
CNTs has similar viscoelastic property to that observed in soft-tissue membrane, so they
have been used to icrease the Yong’s modulus and tensile strength of the hybrid
biomaterials.16,19,20
In this study, we used MWCNT-reinforced collagen scaffolds to investigate the
osteogenic differentiation of MSCs. The overall goal is to develop scaffolds that provide
enhanced mechanical and functional properties in a variety of tissue engineering
applications, by augmenting the properties of naturally derived polymers through
incorporation of carbon nanotubes. Our study was spurred by the following questions: 1)
How CNT-based materials affect cellular processes (e.g. renewal, metabolic activity, and
differentiation) of MSCs? 2) Does this addition of CNTs into naturally derived polymers
result in creating stiffer environment in which osteoprogenitor cells may prefer to be
differentiated into osteocytes? To address the above issues, we incorporated different
concentrations and types of multi-walled CNTs (MWCNTs) into reconstituted type I
collagen, and evaluated proliferation, differentiation, mineralization, and inflammatory
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response of mesenchymal stem cells (MSCs) on these MWCNT-collagen scaffolds.
Alkaline phosphatase (AP) activity and mineralized nodules of extracellular matrix (ECM)
were monitored as osteogenic differentiation markers. Collagen itself enhanced MSCs
differentiation and mineralization due to its nanoscale feature. MWCNTs added to
collagen scaffolds induced an additional increase in MSCs differentiation and
mineralization. MWCNT-collagen scaffolds induced significantly higher level of AP
activity than plastic surface and increased ECM mineralization 12 days after replacement
with differentiating media. Additional increase in MSC differentiation and mineralization
may be due to the increased stiffness and tensile strength of MWCNT-collagen scaffolds.
3.3 Materials and Methods
3.3.1Materials and Reagents
HiPco derived MWCNT, MWCNT-OH and MWCNT-COOH were purchased
from Cheap Tubes Inc (Brattleboro, VT). Rat tail collagen type I was purchased from BD
bioscience (Rockville, MD). Alamar Blue™, Quant-iT™ PicoGreen® dsDNA detection
kit, and rat interleukin 6 (IL-6) CytoSet™ was purchased from Invitrogen Corporation
(Carlsbad, CA).
3.3.2 Isolation and Culture of rat MSCs
The rat femurs were removed under aseptic conditions and the connective tissue
was excised. The epiphyses were removed from the femurs and the cavity was washed
twice with phosphate buffered saline (PBS) solution with 1% penicillin/streptomycin to
isolate bone marrow. The solution was centrifuged at 1000 rpm for 10 minutes, and the
PBS was extracted. The MSCs were resuspended in Dulbecco’s Modified Eagle’s
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Medium (DMEM) with other supplements: 10% fetal bovine serum (FBS), 5 ml of
penicillin/streptomycin, and 1 ml of amfotericin. Most of MSCs were at or between
osteoprogenitor and pre-osteoblast stage. The MSCs were seeded at a density of 4×104
cells/well on MWCNT-collagen scaffolds and incubated at 37°C and 5% CO2. The MSCs
can be differentiated to the osteoblastic phenotype by the addition of 10 mM of βglycerophosphate, 50 μg/ml of ascorbic acid, and 10 nM of dexamethasone.
3.3.3 Dispersion of MWCNTs
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of MWCNTs
(20 - 30 nm in diameter) with two different length (long; 10-

- 2.0

and sonicated for 10 minutes with a 10 second cooling
time per 1 minute sonication cycle using a Sonicator 3000 manufactured by Misonix
(Farmingdale, NY). After sonication, a nontoxic surfactant polyvinylpyrrolidone (PVP)
(Fisher Scientific, PA) was added to the SWCNT solution to inhibit the aggregation of
MWCNTs in the solution.
3.3.4 Preparation of MWCNT-collagen scaffolds
Different concentrations (10, 50, 100, and 855 ppm) of MWCNTs was formulated
into a fixed concentration of collagen type I (1 mg/ml) with 10% NaHCO3. 1000 µl of
MWCNT-collagen mixture were transferred to each well of 24 well plates, and cell
incubated for 30mins at 37 oC.
3.3.5 Cell viability assay
The Alamar blue assay (Biosource International, Camarillo, CA, USA) is
designed for the measurement of cell viability. It incorporates a fluorometric indicator
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based on detection of metabolic activity. The oxidized form of Alamar blue (AB), which
has little intrinsic fluorescence, becomes reduced in viable cells, and the reduced form of
the AB is highly fluorescent. The viability of the cells can be quantified by the extent of
this conversion 21. As negative control, AB was added to the medium without cells. The
plate was further incubated for 1hour at 37.0 0C. To examine cell viability, MSCs were
loaded with Alamar blue at the final concentration of 10%. Under each experiment,
fluorescence of Alamar blue was measured on three separate cell monolayers at an
excitation wavelength of 545 nm and an emission wavelength of 590 nm by a
fluorescence microplate reader (Synergy HT Multi-Mode Microplate Reader, Bio-Tek).
The cell viability was calculated as the ration of fluorescence intensity in treated to
untreated cells.
3.3.6 Quantification of DNA contents
The Quant-iT PicoGreen assay is a method used to quantify DNA. It is a
nonspecific method that relies strictly on the total amount of DNA present rather than the
presence of a specific gene. Briefly, cells were washed once with phosphate-buffered
saline (PBS) after removal of culture medium andlysed in 200 ml of 25mM Tris/0.5%
Triton X-100 (pH 8) solution followed by three freeze/thaw cycles. Quantification of
DNA contents was conducted according the manufacturer's instructions (Molecular Probe,
TX). Fluorescence intensity was measured at an excitation wavelength of 480 nm and an
emission wavelength of 520 nm by a fluorescence microplate reader (Synergy HT MultiMode Microplate Reader, Bio-Tek).

42
3.3.7 Alkaline phosphatase (AP) activity
The alkaline phosphatase (AP) detection is designed for the measurement of cell
differentiation.Calf intestinal alkaline phosphatase (CIAP) for AP Detection was
purchased from Promega (Madison, WI). The substrate (0.4mM of CSPD with Sapphire
II, CD100RX) for AP was purchased from Applied Biosystems (Carlsbad, CA).
Preparation method of cell lysates was same as a quantification method of DNA contents.
Chemiluminescence of AP activity in each sample was detected by a chemiluminrscence
microplate reader (Synergy HT Multi-Mode Microplate Reader, Bio-Tek). The light
output from each sample was integrated for 10 seconds after a 2 second delay.
Chemiluminescence data were calibrated with a CIAP standard curve to present AP
activity.
3.3.8 Interleukin 6 expression
Levels of IL-6 were determined by specific sandwich ELISAs, according to the
manufacturer’s instructions. IL-8 human antibody pair and buffer kit were purchased
from Invitrogen (Carlsbad, CA).
3.3.9 Von Kossa Staining
The cell cultures were washed twice with PBS, fixed in phosphate buffered
formalin for 10 min, washed once with de-ionized water, and serially dehydrated in 70%,
95%, and 100% ethanol two times and dried. The cells were then rehydrated in 100%,
95%, 80% EtOH, and de-ionized water. After addition of 5% silver nitrate solution, the
wells were exposed to sunlight for 20 minutes (or light for 2 h) after which the plate was
rinsed with water. After addition of sodium thiosulfate (5%) for 3 minutes, the cells were
then rinsed in water. Acid fuchsin counterstain (5 ml of 1% acid fuchsin + 95 ml of picric
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acid + 0.25 ml of 12N HCL) was added to cell layers for 5 minutes. The cells were
washed with de-ionized water, twice with 95% EtOH, twice with 100% EtOH, and dried
for image analysis .The number of mineraized nodules was quantified using a 10 X
objective.22
3.3.10 Measurement of mechanical and surface
property of MWCNT-collagen scaffolds
The surface properties of MWCNT-collagen scaffolds were investigated by water
contact angle (WCA) measurement. A 2 μL water droplet was dripped on the dried
surface of a MWCNT-collagen scaffold. The image was captured 6 seconds after the
water droplet was dripped on the surface. Contact angles (left and right) were measured
by an optical contact angle meter (VCA Optima, AST products Inc.).
Compressive testing was performed on MWCNT-collagen scaffolds in wells of a
24 well plate. The height of each sample from the bottom of the well was approximately
5 mm, and the surface are of the bottom of the well was 1.9

. The diameter of the

probe that was used was 10 mm. The test was performed at and extension rate of 10
mm/min until failure was reached, using an Instron 5542 apparatus (Instron, Norwood,
MA). Yong modulus was determined from the elastic regime slope of stress–strain curves
(<40% strain).
3.3.11 Statistical Analysis
Statistically significant differences were set p≤ 0.05. Statistically significant
differences were set p≤ 0.05. Statistical analyses were carried out using one-way analyses
of variance (ANOVA) followed by Dunnett’s multiple comparison tests.
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3.4 Results
3.4.1 Effect of concentration of MWCNTs on
MSC’ differentiation in MWCNT-collagen scaffolds
Different concentrations of MWCNTs were added to collagen scaffolds. MSCs
were seeded onto the MWCNT-collagen scaffolds. When MSCs reach confluence, the
cell culture media was replaced with differentiating media. AP activity was measured at
four day interval. Collagen itself enhanced MSCs differentiation. MWCNTs added to
collagen scaffolds induced an additional increase in MSCs differentiation. MWCNTcollagen scaffolds induced significantly higher level of AP activity than plastic surface 12
days after replacement with differentiating media. MWCNT-Collagen scaffold-induced
AP activities were not dose dependent (Figure 3.1). Although AP levels were higher in
MWCNT-scaffolds at all concentrations of MWCNTs, transparency of the scaffolds
reduced as the concentrations of MWCNTs increased (Figure 3.2). Transparency of the
MWCNT-collagen scaffolds was good at lower MWCNT concentrations (<100ppm of
MWCNTs), but was significantly reduced at higher MWCNT concentrations (>100 ppm
of MWCNTs).
3.4.2 Effects of different types of MWCNT-collagen
scaffolds on MSC’ differentiation
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of MWCNTs
with two different length were added to collagen scaffolds at 10 ppm of MWCNTs.
When MSCs reach confluence, the cell culture media was replaced with differentiating
media. AP activity was measured at four day interval. AP activity increased as the cells
were differentiated on all different types of MWCNT-collagen scaffolds. The level of AP
activity of MSCs was higher on all different types of MWCNT-collagen scaffolds. At the
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day 12, all types of MWCNT-collagen scaffolds induced the higher level of MSC
differentiation, compared to the plastic surface and collagen controls (# p<0.05) (Figure
3.3). However, different types of MWCNTs did not show significantly differences in AP
activity on MWCNT-collagen scaffolds.
3.4.3 Effects of different types of MWCNT-collagen
scaffolds on the formation of mineralized matrix nodules
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of MWCNTs
with two different length were added to collagen scaffolds at 10 ppm of MWCNTs.
When MSCs reach confluence, the cell culture media was replaced with differentiating
media. As the days increased, MSCs induced the increased mineralized nodules. The area
of mineralized matrix nodules was significantly higher at day 15 (Figure 3.4). Especially,
MSCs on both MWCNT-collagen (short) and MWCNT-OH-collagen (short) scaffolds
induced significant increase in mineralization of matrix nodules (Figure 3.4).
3.4.4 Effects of MWCNT-collagen scaffolds on
cell viability and cell proliferation
There was no significant change in cell viability among different types of
MWCNT-collagen. Significant decrease in cell viability on MWCNT-collagen scaffolds
was observed only at day 4 (Figure 3.5A). All types of MWCNT-collagen scaffolds did
not induce a detrimental effect on cell proliferation (Figure 3.5B). In most cases, cell
proliferation was increased during this period.
3.4.5 Effects of MWCNT-collagen scaffolds on inflammatory response
The levels of IL-6 expression did not change significantly as the days increased.
However, IL-6 levels were significantly lower on all types of functionalized MWCNT-
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collagen scaffolds, except MWCNT (long)-collagen scaffolds,

than plastic surfaces

(Figure 3.6) (# p<0.05).
3.4.6 Mechanical properties of MWCNT-collagen scaffolds
Contact angles of collagen scaffolds are higher than those of plastic surface, but
they are not significantly different. There was no significant difference in contact angles
among different types of MWCNT-collagen scaffolds (Figure 3.7). The elastic modulus
increases with the addition of MWCNTs to the collagen gels. The stiffness was varied as
we increased the concentrations of MWCNTs in collagen scaffolds.

50 ppm of

MWCNTs in MWCNT-collagen scaffolds showed significantly higher stiffness than
others (Figure 3.8).
3.5 Discussion
All cells or tissues are exposed to the specific microenvironments that are
generated locally at the micro- or nano-scale level by cell–cell, cell-soluble factor, or
cell–extracellular matrix interactions and that influences cell functions in their tissues.
Especially, each cell type is specifically tuned to the specific microenvironments in
which it resides. For example, the brain tissues are softer than bone tissues. Consequently,
neural cell growth, survival and differentiation are favored by a highly compliant matrix.
By contrast, osteoblast differentiation and survival occurs preferentially on stiffer
extracellular matrices with material properties more similar to newly formed bone
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.

ECM or ECM-like structure can create cellular microenvironment for specific cells or
tissues. In addition to creating cellular microenvironment using ECMs, nanomaterials can
be used to compensate for ECM scaffold limitations such as weak mechanical properties,
lack of electrical conductivity, and the absence of microenvironment-defining moieties.16
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We hypothesized that augmenting the properties of naturally derived polymers (collagen,
in this study) through incorporation of MWCNTs might enhance in vitro osteogenic
differentiation and mineralization of MSCs.
In our study, MWCNTs were distributed in collagen matrix, and strongly
entrapped in collagen (1 mg/ml) at the concentrations below 100 ppm. At these
concentrations (0 - 100ppm), MWCNT-collagen scaffolds showed excellent transparency,
which is appropriate for cell culture and microscopic observation (Figure 3.1). MSCs
were used to mimic the subsequent stages of osteoblastic differentiation in vitro. In the
initial phases of differentiation process, the undifferentiated MSCs became committed
and started to proliferate to osteoprogenitors and pre-osteoblasts subsequently. After we
changed with the differentiating media after 4 days culture in 48well plate on those
scaffolds, pre-osteoblasts were matured into osteoblasts. During this process, matrix was
matured, AP (Figures 3.1 and 3.3) and collagen I were released. Subsequently, cells
started to mature the extracellular matrix and mineralized matrix nodules appeared
(Figure 3.4). Higher level of AP was released from MSCs on MWCNT-collagen
scaffolds and collagen than plastic surface (Figure 3.1). The levels of AP were higher on
all different types of MWCNT-collagen scaffolds than collagen and plastic surface
(Figure 3.3). In addition, MSCs on both MWCNT-collagens (short) and MWCNT-OHcollagen (short) scaffolds induced significant increase in mineralization of matrix nodules
(Figure 3.4).
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Figure 3.1 Effect of concentration of MWCNTs on MSCs’ differentiation in MWCNTcollagen scaffolds. Different concentrations of MWCNTs were added to
collagen scaffolds. MSCs were seeded onto the MWCNT-collagen scaffolds.
When MSCs reach confluence, the cell culture media was replaced with
differentiating media. AP activity was measured at four day interval. *
denotes a significantly higher difference than the control (0 hour) (p<0.05). #
denotes significantly higher difference than both plastic and collagen control
at the same time point (p<0.05).
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Figure 3.2 Transparency of collagen, collagen0 MWCNT composite materials coated
dishes. This shows a comparison of the color and the transparency of the
collagen-coated dish and the MWCNT-collagen coated dish. The MWCNTcollagen coated dish looked slightly gray but had good transparency.
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Figure 3.3 AP activity of MSC cultured on the different types of MWCNT-collagen
scaffolds at 0, 4, 8, and 12 days. * denotes a significantly higher difference
than control (day 0) (p<0.05). # denotes a significantly higher difference than
the plastic and collagen control at the same time point (p<0.05). MWCNT
(L): MWCNT-collagen scaffold (long). MWCNT (S): MWCNT -collagen
scaffold (short).
10ppm.

All types of MWCNT concentration in scaffolds were
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Figure 3.4 Von Kossa staining of MSC cultured on different cell culture matrixes.
Quantification of nodular von Kossa staining using image analysis in the
same experiment. * denotes a significantly higher difference than day 5
control (p<0.05). # denotes a significantly higher difference than the same
time point plastic scaffolds control (p<0.05). All types of MWCNT
concentration in scaffolds were 10ppm.
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Figure 3.5 Effects of MWCNTs on cell viability and cell proliferation on MWCNTcollagen scaffolds. Three different types (MWCNT, MWCNT-OH,
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Figure 3.5 (continued)
MWCNT-COOH) of MWCNTs (20 - 30 nm in diameter) with two different
length (long; 10-20 nm and short; 0.5 - 2.0 nm) were added to collagen
scaffolds at 10 ppm of MWCNTs. When MSCs reach confluence, the cell
culture media was replaced with differentiating media. Cell viability and cell
proliferation were measured after replacement of differentiating media. *
denotes a significantly higher difference than the control (day 0) (p < 0.05).
# denotes a significantly higher difference than the plastic control at the same
time point (p<0.05).
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Figure 3.6

IL-6 expressions from MSC on different types of MWCNT-collagen
scaffolds. Effects of MWCNT-collagen scaffolds on inflammatory response.
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of
MWCNTs (20 - 30 nm in diameter) with two different length (long; 10-20
ort; 0.5 - 2.0 nm) were added to collagen scaffolds at 10 ppm of
MWCNTs. When MSCs reach confluence, the cell culture media was
replaced with differentiating media. IL-6 expresion was measured at four
day interval after replacement of differentiating media. # denotes a
significantly lower difference than the plastic control at the same time point
(p<0.05).
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Figure 3.7 Contact angle measurements on various MWCNT-collagen scaffolds. The
water ability of the surface was investigated by water contact angle (WCA)
measurement. The testing was measured by using a 2 μL water droplet on the
surfaces under ambient conditions with an optical contact angle meter. The
image was captured at 6 s after the water droplet was dripped on the surface.
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Figure 3.8 Measurements of elastic modulus in collagen gels with varying MWCNTCOOH concentration. Compressive testing was performed on MWCNTcollagen scaffolds (191mm2) at 10 mm/min until failure was reached, using
an Instron 5542 apparatus (Instron, Norwood, MA). Yong modulus was
determined from the elastic regime slope of stress–strain curves (<40%
strain). # denotes a significant difference in elastic modulus from the pure
collagen gel.
Structurally, collagen provides tensile strength to tissues via its hierarchical
assembly of collagen subunits. However, in addition to biologic signaling and
macroscopic mechanical properties, collagen also possesses nano-scaled features that are
mediators of cell activity. Previous studies have shown that changes made to certain
features, such as structural curvature of the collagen fibrils, can regulate the activities of
adherent cells. Nano-structure and nano-scale materials play important roles in tissue
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engineering applications. CNTs have been used to modulate cell behavior through their
electrical conductivity, and mechanically to reinforce or tailor the structural properties of
tissue engineered scaffolds. In addition, CNTs have been used to increase the surface
roughness and surface area of scaffolds for cell adhesion.1 In this study, collagen itself
enhanced MSCs differentiation and mineralization due to its nano-scaled feature.
MWCNTs added to collagen scaffolds induced an additional increase in MSCs
differentiation and mineralization. Additional increase in MSC differentiation and
mineralization may be due to the increased stiffness and tensile strength of MWCNTcollagen scaffolds (Figure 3.8). However, it is still not clear that surface properties of
MWCNT-collagen scaffolds affect MSC differentiation and mineralization in this study.
Collagen scaffolds with functionalized MWCNTs (-COOH and -OH) induced
significantly lower level of IL-6 than other scaffolds and plastic surface. Additional
surface analysis and different methods for incorporating nanomaterials will be required to
verify whether surface properties of nanocomposite scaffolds increase or decrease
inflammatory response as well as cell differentiation. Future strategies could involve
incorporating nanoscale materials inside or on the outer surfaces of 3D scaffolds to
investigate mechanical property-dependent changes in cellular processes. A more
complete and fundamental understanding of cellular micro-biomechanics and its
relationship to MSC proliferation and differentiation will be a critical element for the
development of functional tissues in vitro.
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CHAPTER 4
EFFECT OF EXPOSURE CONDITIONS ON SWCNT-INDUCED
INFLAMMATORY RESPONSE IN HUMAN ALVEOLAR EPITHELIAL CELLS
4.1 Abstract
There has been an increasing interest in the development and applications of
carbon nanotubes (CNTs) due to their huge potential in industrial and medical
applications, but the toxicological properties of these materials have not been well
characterized, especially the effects of nanoparticle exposure under different conditions
on cellular responses. Nano-structured particles are potentially hazardous when they
deposit in the respiratory system. In this study, we characterized the effects of single
walled CNT (SWCNT) exposure on interleukin-8 (IL-8) expression in human alveolar
epithelial cells (A549) under various exposure conditions. We measured the level of IL-8
expression in the presence and absence of serum following exposure of SWCNTs. The
results demonstrated that IL-8 expression was enhanced in the presence of serum. When
A549 cells were exposed to low concentrations of SWCNTs, IL-8 expression kept
increasing, even after removal of SWCNTs from the media. In addition, SWCNT
exposure under dynamic cell growth condition induced changes in IL-8 expression.
4.2 Introduction
Nanotechnology has the tremendous potential to improve the effectiveness of a
number of industrial products and could have a substantial impact on the development of
new products in all sectors, ranging from disease diagnosis and treatments to
environmental remediation 1,2. Nanotechnology is anticipated to become the strategic and
dominating science and engineering field of the 21st century. Based on this expectation,
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the U.S. President and the National Science and Technology Council to promote
nanotechnology and to predict that it would lead the United States to the next industrial
revolution.3 Since the discovery of the carbon nanotubes (CNTs) in 1991,4 there has been
an increasing interest in these materials because of their huge potential in industrial and
medical applications. CNTs have been widely used in polymer nanocomposites,5
biomedical applications,6-9 and electronics10 due to their physical, chemical, thermal and
optical properties.11

Consequently, the size of the global market for CNTs has

dramatically increased.12 However, any potentially adverse effects of CNTs have not
been well characterized, especially in the lungs and skin, which are regarded as the most
likely exposure sites during manufacture and material handling.13-19 Possible exposure
conditions of CNTs and their adverse effects will vary among application types and
environments.
Animal studies with engineered nanoparticles have shown some adverse effects
on the lung (e.g., pulmonary inflammation and progressive fibrosis)3,20,21 and
cardiovascular systems (e.g., inflammation, blood platelet activation, plaque formation,
and thrombosis).22-24 Other studies have suggested that discrete nanoparticles may enter
the bloodstream from the lungs and translocate to other organs such as the brain, through
the olfactory nerve.16,25,26 In vitro studies demonstrated that highly purified single walled
carbon nanotubes (SWCNTs) induced the release of inflammatory makers such as nitric
oxide and Interleukin-8 (IL-8).21,27-34 Casey and co-workers also demonstrated the
possible effect of media components on SECNT-induced cellular responses.35 The
interactions among SWCNTs, media components, and cells may affect cell viability,
cellular inflammatory responses, and other toxicological responses. However, the
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mechanisms of these interactions have not been well characterized. In addition, most
cases of in vivo and in vitro studies involved high concentrations of SWCNTs (50~ 800
µg/ml) and extended exposure times (>24 hours).31,33,36,37
This study was spurred by the following fundamental questions: 1) What other
environmental factors may affect the nanoparticle-related inflammatory responses or lead
to cellular toxicity? 2) Are these additional factors related to the translocation of
nanoparticles? 3) Is the nanoparticle-induced inflammatory response alleviated by
removing nanoparticles following exposure? In this study, we monitored the SWCNTinduced IL-8 expression as an inflammatory markers under different exposure conditions,
including concentrations, exposure times, and the presence of serum. We also measured
the SWCNT-induced IL-8 expression in static and dynamic cell growth conditions.
SWCNT-induced IL-8 expression was enhanced in the presence of serum and kept
increasing after removal of SWCNTs, especially following exposure to low
concentrations of SWCNTs. In addition, cellular exposure to SWCNTs in a dynamic cell
growth condition changed IL-8 expression and cell proliferation.
4.3 Materials and Methods
4.3.1 Materials and Reagents
HiPco derived SWCNTs were purchased from Cheap Tubes Inc. (Brattleboro,
VT). The Pierce bicinchoninic acid (BCA) protein assay kit was obtained from Thermo
Fisher Scientific (Rockford, IL). The Human IL-8 CytoSetTM was obtained from
Invitrogen Corporation (Carlsbad, CA).
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4.3.2 Cell Culture
A549 (human alveolar epithelial cells), a human lung adenocarcinoma with the
alveolar type II phenotype, were obtained from the American Type Culture Collection
(ATCC, Manassas, VA). Cells were maintained in T-75 culture flasks in a humidified
incubator at 37oC with 5% CO2 and 95% air, and grown to confluence for 2-3 days in F12K medium (Thermo Fisher Scientific, Rockford, IL). Media was supplemented with
penicillin/streptomycin (Invitrogen, CA) and 10% of fetal bovine serum (Hyclone, UT).
Cells were sub-cultured using trypsin-EDTA (Invitrogen, CA) upon reaching 80-90%
confluence.
4.3.3 Experimental Design
In order to investigate the effect of serum on SWCNT-induced IL-8 expression
and cell proliferation, A549 cells were cultured in 24-well plates at a density of 4×104
cells/well. Cells were incubated until they reached more than 90% confluence and were
then exposed SWCNTs. SWCNTs stock suspensions were made in both the serum free
and serum containing media. Cells were exposed to two different concentrations (4 μg/ml
and 8 μg/ml) of SWCNTs for 0, 1, 3, 6 and 24 hours (Figure 4.1). Cell and media
samples were collected and immediately stored at -80oC until analysis.
In order to study the effects of exposure time on SWCNT-induced IL-8
expression and cell proliferation, A549 cells were prepared and incubated in the same
manner described above, but were exposed to six different concentrations (2, 4, 8, 20, 40,
and 80 μg/ml) of SWCNTs in the serum containing media for 0, 1, 3, 6 and 24 hours
(Figure 4.2). Cell and media samples were collected and immediately stored at -80oC
until analysis.
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To study the effects of exposure and recovery time on SWCNT-induced IL-8
expression and cell proliferation, A549 cells were prepared and incubated in the same
manner described above. Cells were exposed to two different concentrations (4 and
40μg/ml of SWCNTs in serum containing media for 6 (Figure 4.3) and 24 hours (Figure
4.4). Following exposure to SWCNTs, the culture media containing SWCNTs was
replaced with the fresh SWCNT-free media. Cells grew in the fresh media up to 96 hours.
Cell and media samples were collected and immediately stored at -80oC until analysis.
For experiments implementing a dynamic cell growth environment during
SWCNT exposure, A549 cells were seeded at 3×105 cells (per well) into six well BioFlex
plates (Flexcell International, PA) containing 2 ml of complete F-12k medium. After cells
reached confluence, they were exposed to SWCNTs at different concentrations (5, 10,
and 20 μg/ml) under static or dynamic conditions for 24 hours. The dynamic cell growth
condition was implemented using Flexcell® Tension Plus™ 4000T system, which used
vacuum pressure to apply cyclic strain to cells cultured on BioFlex plates. During the
course of dynamic cell growth, cyclic stretching was applied to silastic well-bottoms of
BioFlex plates to attain 5% surface elongation at the frequency of 0.2 Hz, which
corresponds to 45% of the total lung capacity, similar to the normal breathing conditions
in the lung (Tschumperlin and Margulies, 1998). Directly after 24 hour exposure, both
media and cell lysate samples were collected and stored at -80°C until analysis.
4.3.4 Preparation of SWCNTs
The residual metal content of the SWCNTs used in this study was 3% - 12% by
weight, and the individual size ranges of SWCNTs were 0.8-1.2nm in diameter and 1001000nm in length. The SWCNTs were added to distilled water and sonicated for 10
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minutes with 10 second cooling time per 1 minute sonication cycle using Sonicator 3000
manufactured by Misonix (Farmingdale, NY). After sonication, a nontoxic surfactant
polyvinylpyrrolidone (PVP) (Fisher Scientific, PA) was added to the SWCNT solution to
inhibit the aggregation of SWCNTs in the solution. Stock suspensions of SWCNTs were
added to cell culture media (F-12K) with or without 10% of fetal bovine serum.
4.3.5 Cell Proliferation Assay
Cells grown in each well were lysed using 100 µL of triton X-100 following each
exposure condition and stored at -80°C until analysis. Total protein concentrations from
each sample were measured using a BCA total protein assay (Pierce, IL) to evaluate cell
proliferation.
4.3.6 Interleukin 8 Expression
Levels of IL-8 were determined from the supernatant of A549 cells by specific
sandwich ELISAs, according to the manufacturer’s instructions. IL-8 human antibody
pair and buffer kit were purchased from Invitrogen (Carlsbad, CA).
4.3.7 Statistical Analysis
Statistically significant differences were set p ≤ 0.05. Statistical analyses were
carried out using one-way analyses of variance (ANOVA) followed by Dunnett’s
multiple comparison tests.
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4.4 Results
4.4.1 Effects of SWCNTs on Cell Proliferation
and IL-8 Expression in Serum-containing and Serum-free media
As the exposure time increased, IL-8 expression dramatically increased following
cellular exposure to SWCNTs in serum-containing media. The level of IL-8 expression
in serum-containing media was significantly higher than the control (1 hour exposure)
after 24 hours of exposure at both concentrations (4 μg/ml and 8 μg/ml) (Figure 4.1A).
Cell proliferation was not significantly diffrent as exposure time increased at both
concentrations (4 μg/ml and 8 μg/ml). However, cell proliferation was higher in serumcontaining media than in serum-free media at 4 μg/ml of SWCNTs (Figure 4.1B).
4.4.2 Effects of Exposure Time on Cell Proliferation
and IL-8 Expression at Different Concentrations of SWCNTs
Cells were exposed to six different concentrations ((2, 4, 8, 20, 40, 80 μg/ml)) of
SWCNTs. IL-8 expression significantly increased (Figure 4.2A) as the exposure time
increased over 24 hours at all concentrations of SWCNTs. However, no significant
changes in cell proliferation were observed at most concentrations of SWCNTs during 24
hour exposure.
4.4.3 Effects of Recovery Time on SWCNT-induced
IL-8 Expression and Cell Proliferation
Following exposure to SWCNTs at a lower concentration (4 µg/ml) for 6 hours,
the media was replaced with fresh SWCNT-free media. 72 and 96 hours after removing
the SWCNTs, L-8 levels were significantly higher than the levels seen in the control
grown for the same period of time (Figure 4.3A). Protein concentrations were
significantly higher than the 0 hour control, 48 and 96 hour after removing SWCNTs
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(Figure 4.3B). However, following exposure to SWCNTs at a higher concentration (40
µg/ml) for 6 hours, IL-8 expression stopped increasing after removal of SWCNTs (Figure
4.3A). No significant change in cell proliferation was observed in this case (Figure 4.3B).
At a longer exposure time (24 hours), the levels of IL-8 and cell proliferation were
different. Following exposure to SWCNTs at both concentrations (4 and 40 µg/ml) for 24
hours, IL-8 expression significantly increased after removal of SWCNTs (Figure 4.4A),
but cell proliferation significantly decreased at both concentrations (4 and 40 µg/ml) even
after removal of SWCNTs (Figure 4.4B).
4.4.4 Effects of Dynamic Environment on SWCNT-induced
IL-8 Expression and Cell Proliferation
To demonstrate the effects of dynamic cell growth conditions on the SWCNTinduced IL-8 expression and cell proliferation, cells were grown in a dynamic cell
growth condition while being exposed to SWCNT at 5, 10, and 20 μg/ml for 24 hours
(Figure 4.5). Following exposure to SWCNTs for 24 hours, A549 cells grown in the
dynamic cell growth condition showed a significant increase in IL-8 level at all exposure
concentrations as compared to cells grown in the static condition. Under the dynamic cell
growth condition, the IL-8 levels at all SWCNT concentrations (5, 10, and 20 μg/ml)
were significantly higher than the control (0 μg/ml after 24 hour cyclic stretching). Under
static cell growth condition, IL-8 level was significantly higher at 20 μg/ml of SWCNTs
than the control (0 μg/ml under static condition) (Figure 4.5A). Dynamic cell growth
conditions also altered cell proliferation during the exposure of cells to SWCNTs. After
24 hours of cyclic stretching in the dynamic growth environment, cells demonstrated
increased proliferation regardless of whether SWCNT was present in their media,
however, cells grown under static conditions did not demonstrate the same increase.
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Following cyclic stretching for 24 hours, A549 cell proliferation was enhanced either in
the absence (0 µg/ml) or presence (20 µg/ml) of SWCNTs (Figure 4.5B). However, cell
proliferation was not significantly changed following exposure to SWCNTs under static
cell growth condition. There was no significant difference in cell proliferation between
static and dynamic cell growth conditions at SWCNTs concentrations of 5 and 10 μg/ml
of. Cell proliferation at SWCNT concentration of 10 μg/ml of was significantly lower
than the control (0 μg/ml after 24 hour cyclic stretching) under dynamic cell growth
conditions (Figure 4.5B).
4.5 Discussion
In this study, we evaluated the pro-inflammatory effect of SWCNTs on A549
cells under several different exposure conditions. SWCNT-induced IL-8 expression was
enhanced in the presence of serum. IL-8 expression was induced by SWCNTs and kept
increasing even after removing SWCNTs; especially following exposure to lower
concentrations of SWCNTs. SWCNT exposure under dynamic cell growth conditions
induced changes in IL-8 expression and cell proliferation. However, we did not observe
any significant change in IL-8 expression with increasing concentration, although we
observed significant change in the levels of another inflammatory marker (i.e. nitric oxide
(NO) in both A549 and primary normal human bronchial epithelial (NHBE) cells in a
previous publication
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. Interestingly, Herzog and co-workers showed that SWCNT

suppressed inflammatory responses (IL-8 and IL-6 expression) in A549 cells
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. In the

case of nanomaterials, the uncertainties are great because the characteristics of
nanoparticles may be different from those of larger particles with the same chemical
composition.
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Figure 4.1 Effects of SWCNTs on cell proliferation and IL-8 expression in serumcontaining and serum-free media. IL-8 was measured by ELISA (Figure

70
Figure 4.1 (continued)
4.1A) and total protein concentration was determined by the BCA protein
assay (Figure 4.1B), following exposure of SWCNTs at 4 µg/ml
µg/ml either in the presence (10% of serum in the media) or absence of
serum. * denotes a significant difference between data in the serum
containing and serum free media (p<0.05). # denotes a significantly higher
difference than the 1 hour exposure control (p<0.05).
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Figure 4.2 Effects of exposure time on cell proliferation and IL-8 expression at
different concentrations of SWCNTs. A549 cells were exposed to SWCNTs
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Figure 4.2 (continued)
at six different concentrations, IL-8 and cell proliferation were measured as
exposure time increased. IL-8 was measured by ELISA (Figure 4.2A) and
total protein concentration was determined by the BCA protein assay
(Figure 4.2B). 0 hour were used as control. * denotes a significantly higher
(or lower) difference than the control (0 hour) (p< 0.05).
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Figure 4.3 Effects of recovery time on SWCNT-induced IL-8 expression. A549 cells
were exposed to SWCNTs at low and high concentrations for 6 hours,
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Figure 4.3 (continued)
media was then replaced with SWCNT-free media. IL-8 and cell proliferation
were consistently measured at 0, 24, 48, 96 hour after removal of SWCNTs.
IL-8 was measured by ELISA (Figure 4.3A) and total protein concentration
was determined by the BCA protein assay (Figure 4.3B). Untreated samples
and 0 hour were used as controls. * denotes a significantly higher difference
than the control (0 hour) (p< 0.05). # denotes a significantly higher difference
than the same time point control at 0 µg/ml of SWCNTs (p< 0.05).
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Figure 4.4 Effects of recovery time on SWCNT-induced IL-8 expression. A549 cells
were exposed to SWCNTs at low and high concentrations for 24 hours,
media was then replaced with SWCNT-free media.
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Figure 4.4 (continued)
IL-8 and cell proliferation were consistently measured at 0, 24, 48, 96 hour
after removal of SWCNTs. IL-8 was measured by ELISA (Figure 4.4A) and
total protein concentration was determined by the BCA protein assay (Figure
4.4B). Untreated (0 µg/ml of SWCNTs) and 0 hour samples were used as
controls. *denotes a significantly higher difference than the control (0 hour)
(p< 0.05). # denotes a significantly higher difference than the same time
point control at 0 µg/ml of SWCNTs (p< 0.05).
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Figure 4.5 Effects of the dynamic environment on SWCNT-induced IL-8 expression and
A549 cell proliferation. A549 cells were exposed to SWCNTs at 5, 10, and
20 µg/ml. Cells were grown under static and dynamic cell growth conditions
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Figure 4.5 (continued)
for 24 hours. IL-8 was measured from culture media to characterize the
inflammatory response of A549 cells exposed to different concentrations of
SWCNTs under static and dynamic cell growth conditions (Figure 4.5A).
Total amount of protein was measured from cell lysate of each sample
(Figure 4.5B). * denotes a significantly higher difference than the static
condition at each concentration of SWCNT (p<0.03 in Figure 5A and p<0.05
in Figure 5B). # denote a significantly higher (or lower) difference than the
control for dynamic cell growth condition (p<0.05).
In this study, the changes in cell proliferation were not time-dependent or
insignificant following exposure to SWCNTs. The SWCNT exposure started following
confluence of cells. Some fluctuation in cell proliferation can be explained by likely
damage to cellular components, while cells continued to proliferate. This was especially
evident in the dynamic cell growth condition where part of the cell layers may have
repeatedly detached and been recovered.
Previous studies showed that SWCNTs strongly interact with a large range of
molecular species.38-43 Higher toxicity was previously observed in samples that were
exposure to SWCNTs at high concentrations (400- 800μg/ml) when grown in serum-free
media.44 However, at the lower concentrations (4 and 8 µg/ml) of SWCNTs from this
study, higher inflammatory responses were observed in the presence of serum (Figure
4.1A) while no significant decrease in cell proliferations was observed (Figure 4.1B).
Increased toxicity might be due to nutrient deficiencies and higher concentration of
SWCNTs.44-46 In this study, we observed that more SWNCTs penetrated into the cell in
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the presence of serum (data not shown). Casey and co-workers suggested that SWCNTs
may interact with media components by physical adsorption such as van der Waals force.
They also demonstrated that serum affected the dispersion of the nanotubes.35 Facilitated
translocation of SWCNTs into the cells in the presence of serum might affect the
enhanced IL-8 expression. However, the mechanism of the interaction between SWCNTs
and unknown components of serum is not yet clear.
SWCNTs at high concentration (40 µg/ml) were more agglomerated. When we
replaced the SWCNTs-containing media with fresh culture media following a 6 hour
exposure, the aggregated forms of SWCNTs were more efficiently removed. In this case,
IL-8 expression did not increase after removing SWCNTs following a shorter exposure (6
hour exposure) (Figure 3A). However, IL-8 expression kept increasing even after
removal of SWCNTs following a relatively longer exposure (24 hours) (Figure 4.4A).
Cell proliferation was also reduced after longer exposure times to higher concentrations
of SWCNTs. Although their experimental systems were different from ours, other studies
demonstrated that higher apoptotic cell death was observed at lower SWCNT exposure
concentrations than higher concentrations in mouse model

27,47

. The effects of SWCNTs

on cell proliferation and inflammatory responses were different between experimental
systems (i.e. in vitro and animal model, static and dynamic systems) 48. In our study, the
SWCNT-induced IL-8 expression was significantly higher in the dynamic condition than
in the static condition. An increased level of IL-8 under dynamic cell growth conditions
could be due to the initial increase in IL-8 caused by the implementation of a dynamic
cell growth condition

49,50

. Elevated levels of pro-inflammatory cytokines during

SWCNT exposure under a dynamic cell growth condition may result from the altered
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interaction between SWCNTs and A549 cell monolayers. Moreover, due to this altered
interaction, cell proliferation was dramatically changed under dynamic cell growth
conditions. Our results showed that the levels of inflammatory response could be altered
under different exposure conditions. To identify the mechanisms of nanoparticle-induced
inflammatory response under different exposure conditions, other inflammatory markers
and various candidate biological markers (cellular component, macromolecules, other
metabolic parameters, and cellular function) need to be monitored. In addition,
comparative studies with normal cell lines and novel experimental set-ups for
multiplexed screening of biological markers will be required to unravel the uncertainty of
nanoparticle-induced inflammatory responses

51

. Continued in vivo and in vitro

toxicological research is needed to identify potential health endpoints related to
occupational exposure to engineered nanoparticles. Epidemiological studies of exposed
workers will be needed to establish associations between exposures to engineered
nanoparticles and adverse health effects and to assess other potential exposure-response
relationships.
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CHAPTER 5
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
5.1 Summary and Conclusions
Carbon nanotubes have been widely used in biomedical engineering and materials
science, especially since researchers suggest CNTs might be able to be used to bone
tissue engineering application. At the same time, the urgent need for toxicological studies
on carbon nanotubes has arisen. The objectives of this research were to estimate the
CNTs-collagen scaffolds in tissue engineering application, and to find out the effect of
exposure conditions on SWCNT-induced inflammatory response in human alveolar
epithelial cells.
5.1.1 Applications of CNTs-collagen scaffolds in tissue engineering
In Chapter 3, we designed CNTs –collagen composite scaffolds using different
types of MWCNT (functionalized and non-functionalized) with good optically
transparent. Then the mesenchymal stem cell’s viability, differentiation, mineralization
and inflammatory response on those scaffolds were studied. The aim of this study was to
test whether those type of scaffolds can improve mesenchymal stem cell differentiation
and mineralization without changing too much of the cell viability and inflammatory
marker release. The cell differentiation and mineralization levels were higher in the
MWCNTs and collagen mixture scaffolds than the plastic-only and collagen-only were.
The cell viability and inflammatory maker IL-6 level didn’t change too much when
comparing different types of MWCNT-collagen mixture scaffolds. Those results
suggested that MWCNT and collagen mixture scaffolds might be able to provide a good
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nanostructure, mechanical binding and stiffness for MSC differentiation and
mineralization.
5.1.2 Toxicity assessment of SWCNT
In Chapter 4, inflammatory marker (IL-8) expression in human alveolar epithelial
cells under several different exposure conditions of SWCNT was measured. In this study
we found IL-8 expression was enhanced in the presence of serum, and at low
concentrations IL-8 expression kept increasing even after removal of SWCNTs from the
media. We therefore surmise that serum was a defensive response of these lung cells to
SWCNT exposure. Also the less aggregation of low concentrations of SWCNT might be
the reason why IL-8 expression kept increasing even after removing SWCNTs,
SWCNTs without aggregation were easily getting into cell and breaking down some
mechanism of cell.
5.2 Recommendations
There has been a growth of interest in carbon nanotube materials because of their
huge potential in industrial and research applications. Several studies of the application
of carbon nanotubes have been carried for the substrate of cell culture, drug delivery
systems and medical implant materials. However, there are not many researchers using
CNT and collagen to test MSC`s viability and proliferation, especially no studies using
CNT and collagen composite for estimating MSC`s differentation and mineralization.
Our study does show the MWCNT-collagen composite increased in the cell
differentiation and mineralization level, than the plastic and collagen-only surface. But
the mechanism of the interaction between MWCNT, collagen and cell were not clear yet.
Therefore, efforts should be made to force on mechanical study of MWCNT and collagen.
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When considering the possible reason why cell differentiation and mineralization were
changed, it seems important for future studies to address the possible study of the
interaction between the MWCNT and collagen fiber, the surface properties of those
composite scaffolds, and the interaction between the scaffold and cell. In addition,
several studies on the effect of SWCNT on the lung tissue have been reported and there
appears to be some inconsistency between the research findings. The conclusions we got
during our research do show SWCNTs toxicity change at different exposure conditions,
however, the reason behind that is not conclusive yet. Efforts should also be devoted to
identifying the determinate of SWCNTs toxicity. In this respect, it can be recommended
that more in vivo and in vitro toxicological research is needed to identify potential health
endpoints related to occupational exposure to engineered nanoparticles.

